226 related articles for article (PubMed ID: 29383704)
1. Platelets at the crossroads of thrombosis, inflammation and haemolysis.
Vogel S; Thein SL
Br J Haematol; 2018 Mar; 180(5):761-767. PubMed ID: 29383704
[TBL] [Abstract][Full Text] [Related]
2. The platelet NLRP3 inflammasome is upregulated in sickle cell disease via HMGB1/TLR4 and Bruton tyrosine kinase.
Vogel S; Arora T; Wang X; Mendelsohn L; Nichols J; Allen D; Shet AS; Combs CA; Quezado ZMN; Thein SL
Blood Adv; 2018 Oct; 2(20):2672-2680. PubMed ID: 30333099
[TBL] [Abstract][Full Text] [Related]
3. NLRP3 inflammasome and bruton tyrosine kinase inhibition interferes with upregulated platelet aggregation and in vitro thrombus formation in sickle cell mice.
Vogel S; Kamimura S; Arora T; Smith ML; Almeida LEF; Combs CA; Thein SL; Quezado ZMN
Biochem Biophys Res Commun; 2021 May; 555():196-201. PubMed ID: 33831782
[TBL] [Abstract][Full Text] [Related]
4. The NLRP3 inflammasome and bruton's tyrosine kinase in platelets co-regulate platelet activation, aggregation, and in vitro thrombus formation.
Murthy P; Durco F; Miller-Ocuin JL; Takedai T; Shankar S; Liang X; Liu X; Cui X; Sachdev U; Rath D; Lotze MT; Zeh HJ; Gawaz M; Weber AN; Vogel S
Biochem Biophys Res Commun; 2017 Jan; 483(1):230-236. PubMed ID: 28034752
[TBL] [Abstract][Full Text] [Related]
5. Platelet-derived HMGB1 is a critical mediator of thrombosis.
Vogel S; Bodenstein R; Chen Q; Feil S; Feil R; Rheinlaender J; Schäffer TE; Bohn E; Frick JS; Borst O; Münzer P; Walker B; Markel J; Csanyi G; Pagano PJ; Loughran P; Jessup ME; Watkins SC; Bullock GC; Sperry JL; Zuckerbraun BS; Billiar TR; Lotze MT; Gawaz M; Neal MD
J Clin Invest; 2015 Dec; 125(12):4638-54. PubMed ID: 26551681
[TBL] [Abstract][Full Text] [Related]
6. NLRP3 regulates platelet integrin αIIbβ3 outside-in signaling, hemostasis and arterial thrombosis.
Qiao J; Wu X; Luo Q; Wei G; Xu M; Wu Y; Liu Y; Li X; Zi J; Ju W; Fu L; Chen C; Wu Q; Zhu S; Qi K; Li D; Li Z; Andrews RK; Zeng L; Gardiner EE; Xu K
Haematologica; 2018 Sep; 103(9):1568-1576. PubMed ID: 29794149
[TBL] [Abstract][Full Text] [Related]
7. Human NACHT, LRR, and PYD domain-containing protein 3 (NLRP3) inflammasome activity is regulated by and potentially targetable through Bruton tyrosine kinase.
Liu X; Pichulik T; Wolz OO; Dang TM; Stutz A; Dillen C; Delmiro Garcia M; Kraus H; Dickhöfer S; Daiber E; Münzenmayer L; Wahl S; Rieber N; Kümmerle-Deschner J; Yazdi A; Franz-Wachtel M; Macek B; Radsak M; Vogel S; Schulte B; Walz JS; Hartl D; Latz E; Stilgenbauer S; Grimbacher B; Miller L; Brunner C; Wolz C; Weber ANR
J Allergy Clin Immunol; 2017 Oct; 140(4):1054-1067.e10. PubMed ID: 28216434
[TBL] [Abstract][Full Text] [Related]
8. HMGB1 binds to activated platelets via the receptor for advanced glycation end products and is present in platelet rich human coronary artery thrombi.
Ahrens I; Chen YC; Topcic D; Bode M; Haenel D; Hagemeyer CE; Seeba H; Duerschmied D; Bassler N; Jandeleit-Dahm KA; Sweet MJ; Agrotis A; Bobik A; Peter K
Thromb Haemost; 2015 Nov; 114(5):994-1003. PubMed ID: 26202300
[TBL] [Abstract][Full Text] [Related]
9. Syk inhibition suppresses NLRP3 inflammasome activation in platelets from sickle cell mice leading to decreased platelet secretion, aggregation, spreading, and in vitro thrombus formation.
Vogel S; Kamimura S; Smith ML; Almeida LEF; Cui X; Combs CA; Quezado ZMN
Thromb Res; 2024 May; 237():18-22. PubMed ID: 38547689
[No Abstract] [Full Text] [Related]
10. High-mobility group box 1 increases platelet surface P2Y12 and platelet activation in sickle cell disease.
Nolfi-Donegan D; Annarapu GK; St Croix C; Calderon M; Hillery CA; Shiva S
JCI Insight; 2024 Mar; 9(5):. PubMed ID: 38456510
[TBL] [Abstract][Full Text] [Related]
11. Regulation and Function of the Nucleotide Binding Domain Leucine-Rich Repeat-Containing Receptor, Pyrin Domain-Containing-3 Inflammasome in Lung Disease.
Lee S; Suh GY; Ryter SW; Choi AM
Am J Respir Cell Mol Biol; 2016 Feb; 54(2):151-60. PubMed ID: 26418144
[TBL] [Abstract][Full Text] [Related]
12. HMGB1: a novel protein that induced platelets active and aggregation via Toll-like receptor-4, NF-κB and cGMP dependent mechanisms.
Yang X; Wang H; Zhang M; Liu J; Lv B; Chen F
Diagn Pathol; 2015 Aug; 10():134. PubMed ID: 26245198
[TBL] [Abstract][Full Text] [Related]
13. Platelet-derived high-mobility group box 1 promotes recruitment and suppresses apoptosis of monocytes.
Vogel S; Rath D; Borst O; Mack A; Loughran P; Lotze MT; Neal MD; Billiar TR; Gawaz M
Biochem Biophys Res Commun; 2016 Sep; 478(1):143-148. PubMed ID: 27449608
[TBL] [Abstract][Full Text] [Related]
14. Nucleotide-binding oligomerization domain 2 receptor is expressed in platelets and enhances platelet activation and thrombosis.
Zhang S; Zhang S; Hu L; Zhai L; Xue R; Ye J; Chen L; Cheng G; Mruk J; Kunapuli SP; Ding Z
Circulation; 2015 Mar; 131(13):1160-70. PubMed ID: 25825396
[TBL] [Abstract][Full Text] [Related]
15. Pleiotropic effects of intravascular haemolysis on vascular homeostasis.
Kato GJ; Taylor JG
Br J Haematol; 2010 Mar; 148(5):690-701. PubMed ID: 19958359
[TBL] [Abstract][Full Text] [Related]
16. Oxidized hemoglobin forms contribute to NLRP3 inflammasome-driven IL-1β production upon intravascular hemolysis.
Nyakundi BB; Tóth A; Balogh E; Nagy B; Erdei J; Ryffel B; Paragh G; Cordero MD; Jeney V
Biochim Biophys Acta Mol Basis Dis; 2019 Feb; 1865(2):464-475. PubMed ID: 30389578
[TBL] [Abstract][Full Text] [Related]
17. Platelet-neutrophil interactions. Possible relevance in the pathogenesis of thrombosis and inflammation.
Bazzoni G; Dejana E; Del Maschio A
Haematologica; 1991; 76(6):491-9. PubMed ID: 1820986
[TBL] [Abstract][Full Text] [Related]
18. Coronary endothelial dysfunction induced by nucleotide oligomerization domain-like receptor protein with pyrin domain containing 3 inflammasome activation during hypercholesterolemia: beyond inflammation.
Zhang Y; Li X; Pitzer AL; Chen Y; Wang L; Li PL
Antioxid Redox Signal; 2015 May; 22(13):1084-96. PubMed ID: 25739025
[TBL] [Abstract][Full Text] [Related]
19. Sickle red cells as danger signals on proinflammatory gene expression, leukotriene B4 and interleukin-1 beta production in peripheral blood mononuclear cell.
Pitanga TN; Oliveira RR; Zanette DL; Guarda CC; Santiago RP; Santana SS; Nascimento VML; Lima JB; Carvalho GQ; Maffili VV; Carvalho MOS; Alcântara LCJ; Borges VM; Goncalves MS
Cytokine; 2016 Jul; 83():75-84. PubMed ID: 27045344
[TBL] [Abstract][Full Text] [Related]
20. The protective effect of formononetin on cognitive impairment in streptozotocin (STZ)-induced diabetic mice.
Wang J; Wang L; Zhou J; Qin A; Chen Z
Biomed Pharmacother; 2018 Oct; 106():1250-1257. PubMed ID: 30119194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
